Polaris Medical S.A.
- Address
- Str. Principala Comuna Baciu 323t, 407062 Suceagu, Romania
Female Urogenital Diseases & Pregnancy Complications
At Polaris Medical S.A. researchers are evaluating new oral therapies to reduce the frequency of stress urinary incontinence episodes in women who are overweight or obese.
- Stress urinary incontinence
- Impact of body weight on pelvic floor function
- Novel pharmacologic agents for continence improvement
- Patient‑reported outcomes and quality of life
The program involves four investigators and aims to provide safer, more effective treatment options for women facing urinary leakage, enhancing daily comfort and confidence.
Neoplasms
A study at Polaris Medical S.A. is testing a targeted drug to improve disease‑free survival for patients with surgically resected non‑small cell lung cancer carrying HER2 mutations.
- HER2‑mutated non‑small cell lung cancer
- Adjuvant targeted therapy after surgery
- Biomarker‑driven treatment strategies
- Long‑term survival and recurrence monitoring
With four investigators leading the effort, the trial seeks to establish a more effective standard of care for this specific lung cancer subgroup, potentially extending patients’ lives.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Boehringer Ingelheim Espana S.A.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Polaris Medical S.A.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations | Boehringer Ingelheim Espana S.A., Boehringer Ingelheim International GmbH | Phase III | Recruiting | Mar 2026 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atezolizumab | 1 | Unknown | 2026-03-05 | 2026-03-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.